FDA Partner Phoebe Mounts will join the American Conference Institute's 4th Annual conference on Biosimilars pre-conference primer on Wednesday, June 5th.
As the industry prepares for the first wave of biosimilar applications, understanding the minutiae of the complicated science behind manufacturing biologics and biosimilars will be crucial when formulating a multifaceted biosimilars licensing and business development strategy. Assessing the actual costs and likelihood of getting a product to the market will require a thorough analysis of the diverse scientific, legal, and regulatory factors.
Conference | June 6-7, 2013
Biologics 101: Translating the Underlying Science Into a Strong Biosimilars Patent Portfolio Strategy
Presenter: Phoebe Mounts
In this in-depth and interactive deep-dive into the underlying scientific principles, scientists on the front lines of research and development will unite with in-house and law firm thought leaders to help companies preparing to traverse the FDA's biosimilar pathway understand how the scientific challenges inherent to biologics and biosimilars development interplay with intellectual property protection and regulatory strategies.
New York Marriott Downtown
New York, NY
Please visit event registration link for more information regarding CLE credit.